Visual Examination of Airway Via Flexible Fiberoptic Scope After Cervical Spine Surgery

Direct Visual Examination of Airway Via Flexible Fiberoptic Scope After Cervical Spine Surgery

Airway swelling and edema after cervical spine surgery(CSS) especially in prone position is the direct cause that prohibits patient from extubation. Anterior cervical discectomy and fusion causes severe peri-vertebral soft tissue swelling that was associated with increased postoperative airway complications.

Facial, lip and tongue edema in combination with the cuff leak test and risk factors are currently served as the bases on whether patient can be extubated after spine surgery. Direct visualization of the larynx and inside trachea post-operatively to assess the airway directly using flexible fiberoptic scope as well as to quantify the degree of airway edema has not been investigated.

Investigators are comparing airway before and after cervical spine surgery for any degree of narrowing in the airway using flexible fiberoptic scope. Investigators are also studying the risk factors affecting the degree of narrowing in the airway if any

Study Overview

Status

Completed

Conditions

Detailed Description

Because direct visualization of the airway is the most reliable way for the diagnosing and assessing the degree of laryngeal and trachea edema or swelling, investigators sought to do a study to evaluate the degree of airway edema in adult patients undergoing for CSS using direct visualization via flexible fiberoptic and compare the results pre and post- operatively.

The primary outcome will be severity of larynx and trachea edema after cervical spine surgery.

Secondary outcome will be assessment of reliability of airway leak technique and association between face swelling and airway edema.

18 years old and above, 63 number of patient will be enrolled in the study. Patient enrolled who are under going elective cervical spine surgery.Patients involved in the study will be taken to the OR, after induction and prior to intubation asleep flexible fiberoptic scope will be inserted nasally and video record will be taken above and below the glottis, surgery will be continued as planned.

The primary analysis is to test the association of the severity of the laryngeal and tracheal edema with surgical time and number of levels involved in surgery. Investigators will also perform an exploratory analysis to examine the impact of other potential risk factor, including age, fluids and blood products transfusions, ASA( American Society of Anesthesiology) physical status, facial swelling and cuff leak After conclusion of surgery, and when patients are ready for extubation. Quantitative cuff leak will be done, flexible fiber optic scope will be placed through the endotracheal tube, and at the same time of extubation fiber optic scope will be pulled slowly with the endotracheal tube while recording video until we reach a point that approximate same point video was taken prior to intubation, patients who will remain intubated nasal scope will be placed and video will be taken above the glottis with the endotracheal tube in place, another video will be taken for the airway from inside the endotracheal tube.

Study will be aborted if significant resistance during placement of the fiberoptic scope, nasal bleeding happens or hypoxemia requiring ventilation.

Pictures will be saved on USB device and will be assigned a random code that is non-leading to which videos were taken before surgery and which were taken after surgery. Recording prior to intubation will be done as we are withdrawing the scope out, so the motion will be similar to the motion in the video recorded with extubation, hoping that this will be less leading to the blinded ENT surgeon to which was taken before and which after. Patient that will be kept intubated are not blinded.

Pictures will be then shown to ENT surgeon to assess and compare preoperative and postoperative outcome.

Severity of the laryngeal tracheal edema is classified into mild, moderate, and severe. According to the reduction of the cross-section of the trachea lumen, Mild edema is defined as reduction <30%, Moderate < 50%, severe >50% (8).

ENT surgeon will grade the degree of narrowing in the trachea to:

  1. No edema to < 30%
  2. 31%-50%
  3. > 50%.

And above the trachea into

  1. none.
  2. mild.
  3. severe.

Study Type

Observational

Enrollment (Actual)

19

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Syracuse, New York, United States, 13210
        • SUNY Upstate Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing multilevel cervical spine surgery are recruited as study subjects.

Inclusion and exclusion criteria as described above

Description

Inclusion Criteria:

  1. Adult patient age 18-70 years.
  2. Elective cervical spine surgeries involving in upper CSS, ≥ 2 levels, surgical duration ≥ 2 hours
  3. ASA class <4

Exclusion Criteria:

  1. RSI (rapid-sequence induction) and patients with high aspiration risk (postpartum).
  2. Emergency surgery
  3. Angioedema
  4. History of airway malignancy.
  5. Recent upper airway surgery.
  6. Significant recent upper airway infection or abscess.
  7. History of radiation therapy
  8. Nasogastric tube in place.
  9. Tracheostomy in place.
  10. History of basal skull fracture or extensive maxillofacial fracture.
  11. Severe nasal septum deviation.
  12. Morbid obesity BMI > 40.
  13. Surgery involves in C1.
  14. History of epistaxis or bleeding disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Cervical spine surgery patients
Patients undergoing multilevel cervical spine surgery at Upstate University hospital

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of airway swelling - subglottic and supraglottic
Time Frame: 24 hours
Surgical time and number of levels involved in surgery as factors affecting degree of airway swelling.
24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Degree of airway swelling - subglottic and supraglottic
Time Frame: 24 hours
Examine the impact of other potential risk factors including age, fluids and blood products transfusions, ASA status, facial swelling and cuff leak.
24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Luay Nubani, MBCHB, State University of New York - Upstate Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2016

Primary Completion (Actual)

November 12, 2019

Study Completion (Actual)

November 12, 2019

Study Registration Dates

First Submitted

September 5, 2018

First Submitted That Met QC Criteria

January 18, 2024

First Posted (Actual)

January 30, 2024

Study Record Updates

Last Update Posted (Actual)

January 30, 2024

Last Update Submitted That Met QC Criteria

January 18, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 905477-11

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.